• Name of Head of Department :  Dr. Santa Kumar Das

Department introduction/description : Department of Pulmonology and Critical Care Medicine is a tertiary referral center for pulmonary diseases. The department has done consistent work in pulmonary medicine benefitting patients in the field of COPD, Interstitial Lung Diseases, Pulmonary infectious diseases, asthma and tuberculosis. Besides, the department is taking the leadership in managing critically ill patients in Medical Intensive Care Units. The department is equipped with multiple diagnostic modalities – pulmonary function testing, fiber optic bronchoscopy, medical thoracoscopy. Installation of Polysomnography Lab for management of Sleep Disorders in on process. In addition to the clinical activities, the department has been involved in medical education as well as research activities

Key Features

• Has long been serving as a unit under Department of Internal Medicine since 2007 and proven its quality over the years of its service.
• Department came into existence since 2015.
• Highly experienced, skilled and dedicated faculty
• Clinical Observer ship provided to the elective students from countries abroad
• Incorporating the advances in diagnostics in pulmonary medicine
• Dedicated Pulmonary Ward/HDUs and Medical ICU set up
• Dedicated Interventional Pulmonology suite

• Department vision, mission and goals :

The overall goals of the department are to provide world-class excellence in patient care, education, research and advocacy for respiratory diseases, and to train the next generations of leaders in this field.

Education:

1. DM in Pulmonology and Critical Care Medicine

      Services:

1. Well-equipped level 3 Sleep Lab
2. Upgradation of Interventional Pulmonology Lab
3. Immunology services

       Research:

1. Lung Health Research Project in collaboration with John Hopkins University, USA.
2. To conduct research on more candidate vaccines in collaboration with International Vaccine Institute, Korea.

• Department faculty members

S.N.	Full Name	Designation	Full Academic Qualifications (Bachelor onwards)	Joined year	Remarks
1	Dr. Santa Kumar Das	Professor Associate	MD	2007
2	Dr. Niraj Bam	Professor Associate	MD	2007
3	Dr. Pankaj Pant	Professor Associate	MD	2012
4	Dr. Prashu Ram Bista	Assistant Professor	MD, DM	2024

• Academic programs and students educated/trained each year / total

Level	S.N.	Program name	Tick / Yes / No
Bachelor	1	MBBS	Yes
	2	BDS	Yes
Masters	3	MD Internal Medicine	Yes
Super-specialty	4	DM	Yes ( Critical Care Medicine)

• List of hospital clinical services provided and Number of patients served/treated

Out patient department(OPD):

• Tuesday and Thursday: 9 AM to 1 PM (Total Patient: 300+ in each OPD)
• Sunday                         :2 PM to 4 PM  (Total Patient : 100+)

Daily Round:

• Suresh Wagle Memorial Cancer Center, HDU A + HDU B: 15-20 patients per day
• Annex III(Respiratory Ward) and Respi HDU: 20-22 patients per day
• Medical ICU: 8 patients per day
• Other wards: 8-10 patients per day
• Consultation services to other specialties: 8-10 patients per day

Procedure :

• Pulmonary Function Test/ DLCO: 50-60 tests per week
• Bronscopy(BAL +Biopsy)/ Medical Thorasocopy: 12-14 procedures per week

• Teaching Learning Activities:
  • Pulmonology:         Sunday:       Difficult case presentation

                  Wednesday: Journal/Topic Presentation

• Internal Medicine:  Monday:      Topic Presentation

                                      Wednesday: Case discussion

                                      Friday:         Journal Club

• UnderGraduates: Theory class Monday , Bedside class ( Sun/Mon/Friday)

• Research activities of the faculties/department (last 1 year only)
• A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Proof-of-Concept Clinical Trial to Evaluate the Efficacy of Ketotifen fumarate and Indomethacin for Mild and Moderate COVID-19 in Adults ( KICC COVID-19 Study)
• A Phase III, Placebo-controlled, Randomized, Observer-blinded, Multi-national, Multi-center Study to Assess the Safety, Reactogenicity, and Immunogenicity of Heterologous Booster Vaccination of a SARS-CoV-2 Recombinant Protein Nanoparticle Vaccine (GBP510) adjuvanted with AS03 in Adults Aged 18 Years and Older (GBP510_004 Study)
• A parallel-group, Phase III, multi-stage, modified double-blind, multi-armed study to assess the efficacy, safety, and immunogenicity of two SARS-CoV-2 Adjuvanted Recombinant Protein Vaccines (monovalent and bivalent) for prevention against COVID-19 in adults 18 years of age and older. (VAT00008 Study)
• Evaluation of multimodal vital sign devices for reliability and usability in low-resource setting
• Triage Record Analysis (FE010) study
• Evaluation of the effect of brick kiln design on silica and particulate matter exposures, respiratory symptoms and lung function of brick kiln worker and their family members in Bhaktapur, Nepal
• Treatment of cardiovascular disease with low dose Rivaroxaban in Advanced Chronic Kidney Disease (TRACK)

• Number of publications by faculties/department (last 1 year only) – Add relevant fields if needed

Original articles	Review articles	Case reports	Newspaper	Online news	Total
11	0	1	0	0	12